Home
>
National Drug Code (NDC)
>
Forfivo
Forfivo - 49909-010-30 - (bupropion hydrochloride)
Drug Information of Forfivo
| Product NDC: | 49909-010 |
| Proprietary Name: | Forfivo |
| Non Proprietary Name: | bupropion hydrochloride |
| Active Ingredient(s): | 450 mg/1 & nbsp; bupropion hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Forfivo
| Product NDC: | 49909-010 |
| Labeler Name: | Edgemont Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022497 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121001 |
Package Information of Forfivo
| Package NDC: | 49909-010-30 |
| Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (49909-010-30) |
NDC Information of Forfivo
| NDC Code | 49909-010-30 |
| Proprietary Name | Forfivo |
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (49909-010-30) |
| Product NDC | 49909-010 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bupropion hydrochloride |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121001 |
| Marketing Category Name | NDA |
| Labeler Name | Edgemont Pharmaceuticals, LLC |
| Substance Name | BUPROPION HYDROCHLORIDE |
| Strength Number | 450 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA] |
